You are here

• Home
• Therapy Areas
• Cardiovascular

• A Randomized, Single-Blind, Placebo-Controlled, Single-Centre, Phase I Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Food Interaction after Single Ascending Oral Doses of AZD1656 in Healthy Male Subjects

Disease

diabetes mellitus

Drug Name

AZD1656

Generic Name

AZD1656

Sponsor

AstraZeneca

Drug Status

Discontinued

Phase

I

Start Date

Jul 3, 2008

Study Name

D1020C00001

Study Id

D1020C00001

Recruiting Status

Closed

Protocol Status

Not Available

Report

Jan 8, 2009

• D1020C00001.pdf (533 KB)

Page tools

• Print
• Bookmark this page